Clinical and laboratorial characterization of a cohort of patients with hereditary platelet disorders in Brazil Letícia Dalla Vecchia Grassi; Erica Okazaki; Cynthia Rothschild; Paula Villaça; Fernanda Andrade Orsi; Bianca Stefanello;

Benefits of BV-AVD (Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine) versus ABVD (doxorubicin hydrochloride, bleomycin sulfate, vinblastine sulfate, dacarbazine) in patients with advanced-stage Hodgkin's lymphoma: an analysis of the ECHELON 1 trial by the GATLA group using the Delphi Method Astrid Pavlovsky; Juan Ignacio Garcia Altuve; Amalia Cerutti; Lorena Fiad; Nicolás Kurgansky; Fernando Warley; Florencia Negri Aranguren;

Evaluation of C-reactive protein and its prognostic relationship in patients with Hodgkin's Lymphoma Elizete Negreiros; Talita Máira Bueno da Silveira; Sérgio Costa Fortier; Carlos Sérgio Chiattone;